A clinical review of outcomes of the Multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA)
- 22 Downloads
Over the past decade, the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder has provided a bewildering wealth of data (more than 70 peer-reviewed articles) addressing treatment-related questions for children with attention-deficit/hyperactivity disorder. However, the take-home messages for clinicians may not always be clear. Therefore, this article reviews key findings, including relative benefits of medication and behavioral treatments, long-term effects at 2 and 3 years, treatment mediators and moderators, preliminary delinquency and substance use outcomes, and growth suppression related to stimulant use. Appropriate interpretations of the findings and their limitations are discussed, and recommendations for clinical practice are derived.
KeywordsStimulant Medication Acad Child Adolesc Psychiatry Multimodal Treatment Study Clin Child Psychol Clin Child Adolesc Psychol
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 14.Jensen PS, Arnold LE, Swanson J, et al.: Follow-up of the NIMH MTA study at 36 months after randomization. J Am Acad Child Adolesc Psychiatry 2007, 46:988–1001.Google Scholar
- 15.Swanson JM, Hinshaw SP, Arnold LE, et al.: Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry 2007, 46:1002–1013.Google Scholar
- 16.Chen HY, Gibbons RD, Hur K, et al.: A growth mixture model for estimating patterns of change in attention deficit hyperactivity disorder. J Am Stat Assoc 2008 (in press).Google Scholar
- 18.Lahey BB, McBurnett K, Loeber R: Are attention-deficit/ hyperactivity disorder and oppositional defiant disorder developmental precursors to conduct disorder? In Handbook of Developmental Psychology. Edited by Sameroff AJ, Lewis M, Miller SM. Dordrecht, Holland: Kluwer Academic Press; 2000:431–446.Google Scholar
- 22.NIH Consensus Committee: Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consens Statement 1998, 16:1–37.Google Scholar
- 23.Swanson JM, Elliott GR, Greenhill LL, et al.: Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry 2007, 46:1014–1026.Google Scholar
- 24.Caron M: Growth in the dopamine transporter knockout animal model of ADHD. Neuropsychopharmacology 2004, 29:S55.Google Scholar
- 31.Galanter CA, Carlson GA, Jensen PS, et al.: Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol 2003, 13:123–136.PubMedCrossRefGoogle Scholar
- 35.Swanson JM, Wigal T, Arnold LE: Prenatal cigarette exposure, physical size, and stimulant-related growth suppression in relation to a thrifty phenotype: an etiologic subtype of ADHD? Paper presented at the 13th Scientific Meeting of the International Society for Research in Child and Adolescent Psychopathology. London: June 20–23, 2007.Google Scholar
- 49.Medco Publications: 2004 drug trend report. Medco Publications website. Available at http://medco.mediaroom.com/index.php?s=64&cat=5. Accessed January 20, 2009.